These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29153365)

  • 21. MRI of the breast as part of the assessment in population-based mammography screening.
    Bick U; Engelken F; Diederichs G; Dzyuballa R; Ortmann M; Fallenberg EM
    Rofo; 2013 Sep; 185(9):849-56. PubMed ID: 23740312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
    Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
    J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast enhanced digital mammography versus magnetic resonance imaging for accurate measurement of the size of breast cancer.
    Youn I; Choi S; Choi YJ; Moon JH; Park HJ; Ham SY; Park CH; Kim EY; Kook SH
    Br J Radiol; 2019 Jun; 92(1098):20180929. PubMed ID: 31017460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
    Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
    Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced digital mammography and magnetic resonance imaging: reproducibility compared to pathologic anatomy.
    Liguori A; Depretto C; Ciniselli CM; Citterio A; Boffelli G; Verderio P; Scaperrotta GP
    Tumori; 2022 Dec; 108(6):563-571. PubMed ID: 34628982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
    Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Value of Contrast-Enhanced Digital Mammography versus Contrast-Enhanced Magnetic Resonance Imaging for the Preoperative Evaluation of Breast Cancer.
    Kim EY; Youn I; Lee KH; Yun JS; Park YL; Park CH; Moon J; Choi SH; Choi YJ; Ham SY; Kook SH
    J Breast Cancer; 2018 Dec; 21(4):453-462. PubMed ID: 30607168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).
    Amato F; Bicchierai G; Cirone D; Depretto C; Di Naro F; Vanzi E; Scaperrotta G; Bartolotta TV; Miele V; Nori J
    Radiol Med; 2019 Dec; 124(12):1229-1237. PubMed ID: 31773458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality screening of high-risk women: a prospective cohort study.
    Weinstein SP; Localio AR; Conant EF; Rosen M; Thomas KM; Schnall MD
    J Clin Oncol; 2009 Dec; 27(36):6124-8. PubMed ID: 19884532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.
    Kuhl CK; Keulers A; Strobel K; Schneider H; Gaisa N; Schrading S
    Breast Cancer Res; 2018 Feb; 20(1):13. PubMed ID: 29426360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
    Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
    Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
    Chiarelli AM; Blackmore KM; Muradali D; Done SJ; Majpruz V; Weerasinghe A; Mirea L; Eisen A; Rabeneck L; Warner E
    J Natl Cancer Inst; 2020 Feb; 112(2):136-144. PubMed ID: 31233143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI of occult breast carcinoma in a high-risk population.
    Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
    AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
    Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
    Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI breast screening in high-risk women: cancer detection and survival analysis.
    Evans DG; Kesavan N; Lim Y; Gadde S; Hurley E; Massat NJ; Maxwell AJ; Ingham S; Eeles R; Leach MO; ; Howell A; Duffy SW
    Breast Cancer Res Treat; 2014 Jun; 145(3):663-72. PubMed ID: 24687378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.